SCHEMBL1549946

SCHEMBL1549946

CCOC(=O)C(C)(C)Oc1ccc(O)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.48
CYP1A2 P05177 2/20 0.48
ABCB11 O95342 1/20 0.48
CYP3A4 P08684 1/20 0.48
TSHR P16473 1/20 0.48
HTR2A P28223 1/20 0.48
PMP22 Q01453 1/20 0.48
FBP1 P09467 7/20 0.47
CNR2 P34972 4/20 0.42
PPARG P37231 1/20 0.41
HSD17B2 P37059 1/20 0.41
MAOB P27338 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
APP P05067 1/20 0.40
BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15460021 0.86 PPARA (0.55) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL1549824 0.85 FBP1 (0.58) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL1550089 0.85 PPARA (0.50) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL7981278 0.84 FBP1 (0.60) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL3585865 0.83 FBP1 (0.60) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL3904657 0.83 FBP1 (0.52) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL14144766 0.82 PPARA (0.45) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL5605607 0.82 ALDH1A1 (0.56) TSHRFBP1ALDH1A1HPGDHTT
SCHEMBL12670823 0.82 FBP1 (0.56) PPARACYP1A2ABCB11CYP3A4TSHR
SCHEMBL3922298 0.82 PPARA (0.47) PPARACYP1A2ABCB11CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2314576-A1 Phenyl derivatives as PPAR agonists F.HOFFMANN-LA ROCHE AG (CH) 2011-04-27 EP disclosed
US-7115611-B2 Phenyl derivatives, their manufacture and use as pharmaceutical agents HOFFMANN-LA ROCHE INC. (US) 2006-10-03 US disclosed
EP-1682508-A1 PHENYL DERIVATIVES AS PPAR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2006-07-26 EP disclosed
WO-2005049573-A1 PHENYL DERIVATIVES AS PPAR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-06-02 WO disclosed
US-20050096337-A1 Phenyl derivatives, their manufacture and use as pharmaceutical agents HOFFMANN-LA ROCHE INC. 2005-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096337-A1 Phenyl derivatives, their manufacture and use as pharmaceutical agents PPARD, PPARA, PPARG PPARA 2/4885CYP1A2 94/4885ABCB11 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.